These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 8290745
61. A comparative study of the efficacy of beclomethasone dipropionate delivered from a breath activated and conventional metered dose inhaler in asthmatic patients. Woodman K, Bremner P, Burgess C, Crane J, Pearce N, Beasley R. Curr Med Res Opin; 1993; 13(2):61-9. PubMed ID: 8325043 [Abstract] [Full Text] [Related]
62. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids. Wolfe J, Rooklin A, Grady J, Munk ZM, Stevens A, Prillaman B, Duke S, Harding S. J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150 [Abstract] [Full Text] [Related]
63. Comparison between sodium cromoglycate (MDI: metered-dose inhaler) and beclomethasone dipropionate (MDI) in treatment of adult patients with mild to moderate bronchial asthma. A double-blind, double-dummy randomized, parallel-group study. Faurschou P, Bing J, Edman G, Engel AM. Allergy; 1994 Sep; 49(8):659-63. PubMed ID: 7653745 [Abstract] [Full Text] [Related]
64. A single blinded randomised trial to compare the efficacy and safety of once daily budesonide (400microg) administered by turbuhaler with beclomethasone dipropionate (400microg) given twice daily through a metered-dose inhaler in patients with mild to moderate asthma. Ige OM, Sogaolu OM. Afr J Med Med Sci; 2004 Jun; 33(2):155-60. PubMed ID: 15565935 [Abstract] [Full Text] [Related]
66. Adrenal function and high dose inhaled corticosteroids for asthma. Yiallouros PK, Milner AD, Conway E, Honour JW. Arch Dis Child; 1997 May; 76(5):405-10. PubMed ID: 9196354 [Abstract] [Full Text] [Related]
67. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma. van Noord JA, Schreurs AJ, Mol SJ, Mulder PG. Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895 [Abstract] [Full Text] [Related]
68. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group. Perruchoud AP, Lundback B, Yigla M, Sykes AP. Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684 [Abstract] [Full Text] [Related]
69. Fluticasone propionate 100 microg bid using a non-CFC propellant, HFA 134a, in asthmatic children. Lyttle B, Gilles J, Panov M, Emeryk A, Wixon C. Can Respir J; 2003 Mar; 10(2):103-9. PubMed ID: 12687029 [Abstract] [Full Text] [Related]
70. Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. Papi A, Paggiaro P, Nicolini G, Vignola AM, Fabbri LM, ICAT SE study group. Allergy; 2007 Oct; 62(10):1182-8. PubMed ID: 17845589 [Abstract] [Full Text] [Related]
72. Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma. Chan R, Sousa AR, Mallett S, Hynds P, Homayoun-Valiani F, Tabberer M, Mehta R. Pulm Pharmacol Ther; 2016 Dec; 41():19-24. PubMed ID: 27599598 [Abstract] [Full Text] [Related]
74. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler. Selroos O, Halme M. Thorax; 1991 Dec; 46(12):891-4. PubMed ID: 1792636 [Abstract] [Full Text] [Related]
75. Treating asthma in children with beclomethasone dipropionate: Pulvinal versus Diskhaler. De Benedictis FM, Boner A, Cavagni G, Caffarelli C, Ferraro L, Cantini L. J Aerosol Med; 2000 Dec; 13(1):35-41. PubMed ID: 10947322 [Abstract] [Full Text] [Related]
76. A new beclomethasone dipropionate multidose powder inhaler in the treatment of bronchial asthma. Nieminen MM, Vidgren P, Kokkarinen J, Laasonen K, Liippo K, Lindqvist A, Paananen M, Poukkula A, Ruotsalainen E, Salomaa E, Sovijärvi A, Söderblom T, Silvasti M, Vidgren M, Laitinen LA. Respiration; 1998 Dec; 65(4):275-81. PubMed ID: 9730793 [Abstract] [Full Text] [Related]
77. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. Li JT, Ford LB, Chervinsky P, Weisberg SC, Kellerman DJ, Faulkner KG, Herje NE, Hamedani A, Harding SM, Shah T. J Allergy Clin Immunol; 1999 Jun; 103(6):1062-8. PubMed ID: 10359887 [Abstract] [Full Text] [Related]
79. A systemic bioactivity comparison of double-strength and regular-strength beclomethasone dipropionate MDI formulations. Brannan MD, Herron JM, Reidenberg P, Affrime MB. Ann Allergy Asthma Immunol; 1998 Jan; 80(1):39-44. PubMed ID: 9475565 [Abstract] [Full Text] [Related]
80. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study. Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, Faris MA, Crim C. Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]